Results

Total Results: 2,231 records

Showing results for "medication".
Users also searched for: medication reconciliation

101. Archived: Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
     December 12, 2017 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions December 12, 2017 Recommendations made by the USPSTF are independen…

102. Final Research Plan: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/falls-prevention-community-dwelling-older-adults-interventions
     July 21, 2022 - Exercise (supervised or unsupervised, individual or group) Multifactorial assessment and intervention Medication … The intervention name “medication management” was also changed to “medication modification/review” to

103. Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8mY8Vp8f2BntTAbxwX7mYk
     March 22, 2021 - available over the counter, but pregnant people should talk to their healthcare provider before taking the medication … It is based on the quality and strength of the evidence about the potential benefits and harms of medication … When the Task Force issues a B Grade, it recommends the use of a preventive medication because it has … Mortality From Preeclampsia 1 The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication

104. Let’s Talk About It: Preventing HIV with PrEP (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/hiv-prep-prevention-discussion-guide.pdf
     August 22, 2023 - professional determine your risk for HIV, decide whether taking PrEP is right for you, and discuss which PrEP medication … PrEP (pre-exposure prophylaxis) is a medication that can help prevent you from getting HIV. … 2 Which PrEP medication is best for me? 3 How long does it take for PrEP to be effective? … PrEP Formulations and Medication Adherence There are currently several FDA-approved ways that people

105. Archived: Final Evidence Summary: Falls Prevention in Older Adults: Counseling and Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary24/falls-prevention-in-older-adults-counseling-and-preventive-medication
     December 15, 2010 - archived Final Evidence Summary Falls Prevention in Older Adults: Counseling and Preventive Medication … Medication Assessment and Withdrawal We evaluated 1 small trial (48 participants) of medication assessment … Medication assessment and withdrawal of therapy with medication alone were not associated with a reduced … No harms were reported in the trials evaluating withdrawal of therapy with medication. … Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized,

106. Archived: Final Evidence Review: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review52/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication-2011
     July 15, 2011 - Final Evidence Review Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication … Preventive Services Task Force (USPSTF) recommended prophylactic ocular topical medication for the prevention … neonatorum has become rare in the United States since the implementation of providing universal preventive medication

107. Archived: Final Evidence Summary: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary25/folic-acid-to-prevent-neural-tube-defects-preventive-medication
     May 15, 2009 - archived Final Evidence Summary Folic Acid to Prevent Neural Tube Defects: Preventive Medication

108. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
     March 15, 2007 - Evidence Summary: Aspirin Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication … by the disorder (that is, colorectal adenoma vs. colorectal cancer), study design, study sample, and medication … respectively), and both used self-reporting of outcomes in mailed questionnaires, as well as mailed medication

109. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
     March 15, 2007 - archived Evidence Summary: NSAIDs Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication … grouped studies by disorder (that is, colorectal adenoma or CRC), study design, study population, and medication

110. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
     January 15, 2002 - Evidence Summary Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication

111. Final Research Plan: Aspirin to Prevent Cardiovascular Disease: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer
     October 07, 2013 - Cardiovascular Disease Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … history of gastrointestinal bleeding, ulcers, or nonsteroidal anti-inflammatory drug use), or concomitant medication … Comparisons Placebo or no treatment Any active substance or intervention (e.g., nonaspirin medication

112. Archived: Final Research Plan: Aspirin to Prevent Cardiovascular Disease: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     October 07, 2013 - Cardiovascular Disease Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … history of gastrointestinal bleeding, ulcers, or nonsteroidal anti-inflammatory drug use), or concomitant medication … Comparisons Placebo or no treatment Any active substance or intervention (e.g., nonaspirin medication

113. Archived: Aspirin Prophylaxis in Pregnancy: Preventive Medication, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-pregnancy-1996
     January 01, 1996 - archived Final Recommendation Statement Aspirin Prophylaxis in Pregnancy: Preventive Medication … Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … trial, 315 of 919 women failed a 2-week run-in period due to poor compliance with either visits or medication

114. Final Evidence Review: Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
     August 01, 2023 - Final Evidence Review Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication

115. Archived: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
     January 10, 2017 - Final Recommendation Statement Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication … Preventive Medication Folic acid is the synthetic form of folate, a water-soluble B vitamin. … Benefits of Preventive Medication The USPSTF found convincing evidence that folic acid supplementation … Harms of Preventive Medication The USPSTF found adequate evidence that the harms to the mother or infant … benefits of folic acid supplementation differ by dosage or timing. 1 Potential Harms of Preventive Medication

116. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Share to Email Print Evidence Summary Breast Cancer: Medication … Symptomatic effects (eg, vasomotor, musculoskeletal) varied by medication. … No studies specifically compared shorter vs longer regimens of medication use or initiation based on … Furthermore, no trials directly compared the effects of timing and duration of medication use. … Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the

117. Archived: Published Comments and Response: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/published-comments-and-response/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication
     October 15, 2009 - Published Comments and Response Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication

118. Evidence Summary: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
     January 10, 2017 - Evidence Summary Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication … Page/Document/final-evidence-review146/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication … 4,293 619 4167 0.93 (0.82-1.06) BMI ≥30.0, low dietary folate intake, anticonvulsant medication

119. Archived: Final Research Plan: Aspirin to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     October 07, 2013 - to Prevent Cancer Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … , such as age, sex, race/ethnicity, baseline cancer risk † , comorbid conditions * , or concomitant medication … , such as age, sex, race/ethnicity, baseline cancer risk † , comorbid conditions * , or concomitant medication … A proposed Contextual Question on harms of concomitant medication use was integrated into the appropriate

120. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/hEp2uYfD9KRhYTY5fGr8Tp
     October 15, 2018 - Summary of Recommendation and Evidence The USPSTF recommends prophylactic ocular topical medication for … Benefits of Preventive Medication The USPSTF found convincing evidence that ocular prophylaxis of newborns … Harms of Preventive Medication The USPSTF found convincing evidence that ocular prophylaxis of newborns … Potential Harms of Preventive Medication The USPSTF found no new data that would change its previous … Possible harms include the potential for antimicrobial resistance to treatment medication.